Bioeconomy A ‘milestone for biotech industry in Portugal’: Lymphact acquired by UK company Tim Hinchliffe Jun 8, 2018 GammaDelta Therapeutics, which develops immunotherapies for cancer and other diseases, acquires Portugal's biotech startup Lymphact to advance its Gamma delta T cell platform. ... continue reading
Jul 8, 2026 Portuguese founder mapping the world’s empty rooftops looks to expand following investment from Dubai venture firm
